Archive - January 2022
AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
Almirall and IRB Barcelona announce new research collaboration
NICE moves: increased accessibility and flexibility for health tech
New AstraZeneca treatment for rare cancer reduces risk of death
Lack Of Trust In Public Figures Linked To COVID Vaccine Hesitancy – New Research
EMA proposes EU clinical trial reforms
First-of-its-kind NHS gene pilot takes off
Air of optimism surrounds lung cancer vaccine